|
Age (mean ± SD, years)
|
63 ± 11
|
|
Body masse index (mean ± SD, kg/m2)
|
26.6 ± 5.4
|
|
Gender (female/male) (n)
|
41/57
|
|
Simplified acute physiologic score (mean ± SD)
|
64 ± 18
|
|
Sequential organ failure assessment score (median [IQR])
|
10 [6–12]
|
|
ICU mortality [n (%)]
|
42 (42.8)
|
|
Time between diagnosis and inclusion (median [IQR], h)
|
1.7 [1.0–2.0]
|
|
Infection source [n (%)]
| |
|
Pneumonia
|
54 (55)
|
|
Peritonitis
|
34 (35)
|
|
Meningitis
|
5 (5)
|
|
Urinary tract infection
|
5 (5)
|
|
Patients receiving norepinephrine [n (%)]
|
98 (100)
|
|
Norepinephrine dose (median [IQR], µg/kg/min)
|
0.24 [0.11–0.55]
|
|
Patients receiving dobutamine [n (%)]
|
21 (21.4)
|
|
Dobutamine dose (median [IQR], µg/kg/min)
|
5 [5–10]
|
|
Mechanical ventilation [n (%)]
|
98 (100)
|
